133 related articles for article (PubMed ID: 17016515)
21. Additive antinociceptive effects of the selective Nav1.8 blocker A-803467 and selective TRPV1 antagonists in rat inflammatory and neuropathic pain models.
Joshi SK; Honore P; Hernandez G; Schmidt R; Gomtsyan A; Scanio M; Kort M; Jarvis MF
J Pain; 2009 Mar; 10(3):306-15. PubMed ID: 19070548
[TBL] [Abstract][Full Text] [Related]
22. ABT-702 (4-amino-5-(3-bromophenyl)-7-(6-morpholino-pyridin- 3-yl)pyrido[2,3-d]pyrimidine), a novel orally effective adenosine kinase inhibitor with analgesic and anti-inflammatory properties. II. In vivo characterization in the rat.
Kowaluk EA; Mikusa J; Wismer CT; Zhu CZ; Schweitzer E; Lynch JJ; Lee CH; Jiang M; Bhagwat SS; Gomtsyan A; McKie J; Cox BF; Polakowski J; Reinhart G; Williams M; Jarvis MF
J Pharmacol Exp Ther; 2000 Dec; 295(3):1165-74. PubMed ID: 11082454
[TBL] [Abstract][Full Text] [Related]
23. Contribution of the spinal cord BDNF to the development of neuropathic pain by activation of the NR2B-containing NMDA receptors in rats with spinal nerve ligation.
Geng SJ; Liao FF; Dang WH; Ding X; Liu XD; Cai J; Han JS; Wan Y; Xing GG
Exp Neurol; 2010 Apr; 222(2):256-66. PubMed ID: 20079352
[TBL] [Abstract][Full Text] [Related]
24. Synthesis and SAR development of novel mGluR1 antagonists for the treatment of chronic pain.
Brumfield S; Korakas P; Silverman LS; Tulshian D; Matasi JJ; Qiang L; Bennett CE; Burnett DA; Greenlee WJ; Knutson CE; Wu WL; Sasikumar TK; Domalski M; Bertorelli R; Grilli M; Lozza G; Reggiani A; Li C
Bioorg Med Chem Lett; 2012 Dec; 22(23):7223-6. PubMed ID: 23084894
[TBL] [Abstract][Full Text] [Related]
25. Peripheral glutamate receptors contribute to mechanical hyperalgesia in a neuropathic pain model of the rat.
Jang JH; Kim DW; Sang Nam T; Se Paik K; Leem JW
Neuroscience; 2004; 128(1):169-76. PubMed ID: 15450364
[TBL] [Abstract][Full Text] [Related]
26. Intrathecal metabotropic glutamate receptor antagonists do not decrease mechanical hyperalgesia in a rat model of postoperative pain.
Zahn PK; Brennan TJ
Anesth Analg; 1998 Dec; 87(6):1354-9. PubMed ID: 9842826
[TBL] [Abstract][Full Text] [Related]
27. [Research progress of selective mGluR1 antagonists].
Yang YL; Sun W; Peng C; Zhang XY; Yang XH
Yao Xue Xue Bao; 2011 Oct; 46(10):1167-72. PubMed ID: 22242445
[TBL] [Abstract][Full Text] [Related]
28. Effects of a novel metabotropic glutamate receptor 7 negative allosteric modulator, 6-(4-methoxyphenyl)-5-methyl-3-pyridin-4-ylisoxazonolo[4,5-c]pyridin-4(5H)-one (MMPIP), on the central nervous system in rodents.
Hikichi H; Murai T; Okuda S; Maehara S; Satow A; Ise S; Nishino M; Suzuki G; Takehana H; Hata M; Ohta H
Eur J Pharmacol; 2010 Aug; 639(1-3):106-14. PubMed ID: 20371227
[TBL] [Abstract][Full Text] [Related]
29. (R)-(5-tert-butyl-2,3-dihydro-1H-inden-1-yl)-3-(1H-indazol-4-yl)-urea (ABT-102) blocks polymodal activation of transient receptor potential vanilloid 1 receptors in vitro and heat-evoked firing of spinal dorsal horn neurons in vivo.
Surowy CS; Neelands TR; Bianchi BR; McGaraughty S; El Kouhen R; Han P; Chu KL; McDonald HA; Vos M; Niforatos W; Bayburt EK; Gomtsyan A; Lee CH; Honore P; Sullivan JP; Jarvis MF; Faltynek CR
J Pharmacol Exp Ther; 2008 Sep; 326(3):879-88. PubMed ID: 18515644
[TBL] [Abstract][Full Text] [Related]
30. Antinociceptive effects of N-acetylaspartylglutamate (NAAG) peptidase inhibitors ZJ-11, ZJ-17 and ZJ-43 in the rat formalin test and in the rat neuropathic pain model.
Yamamoto T; Hirasawa S; Wroblewska B; Grajkowska E; Zhou J; Kozikowski A; Wroblewski J; Neale JH
Eur J Neurosci; 2004 Jul; 20(2):483-94. PubMed ID: 15233757
[TBL] [Abstract][Full Text] [Related]
31. Pain-related behavior following REM sleep deprivation in the rat: influence of peripheral nerve injury, spinal glutamatergic receptors and nitric oxide.
Wei H; Zhao W; Wang YX; Pertovaara A
Brain Res; 2007 May; 1148():105-12. PubMed ID: 17368427
[TBL] [Abstract][Full Text] [Related]
32. Analgesic activity of metabotropic glutamate receptor 1 antagonists on spontaneous post-operative pain in rats.
Zhu CZ; Baker S; EI-Kouhen O; Lehto SG; Hollingsworth PR; Gauvin DM; Hernandez G; Zheng G; Chang R; Moreland RB; Stewart AO; Brioni JD; Honore P
Eur J Pharmacol; 2008 Feb; 580(3):314-21. PubMed ID: 18054908
[TBL] [Abstract][Full Text] [Related]
33. Long-term synaptic plasticity in the spinal dorsal horn and its modulation by electroacupuncture in rats with neuropathic pain.
Xing GG; Liu FY; Qu XX; Han JS; Wan Y
Exp Neurol; 2007 Dec; 208(2):323-32. PubMed ID: 17936754
[TBL] [Abstract][Full Text] [Related]
34. Virtual screening for selective allosteric mGluR1 antagonists and structure-activity relationship investigations for coumarine derivatives.
Noeske T; Jirgensons A; Starchenkovs I; Renner S; Jaunzeme I; Trifanova D; Hechenberger M; Bauer T; Kauss V; Parsons CG; Schneider G; Weil T
ChemMedChem; 2007 Dec; 2(12):1763-73. PubMed ID: 17868161
[TBL] [Abstract][Full Text] [Related]
35. Potentiation of morphine antiallodynic efficacy by ACPT-III, a group III metabotropic glutamate receptor agonist, in rat spinal nerve ligation-induced neuropathic pain.
Lee HG; Park SK; Yoon MH
Pharmacol Biochem Behav; 2010 Jul; 96(1):108-13. PubMed ID: 20434481
[TBL] [Abstract][Full Text] [Related]
36. Tricyclic thienopyridine-pyrimidones/thienopyrimidine-pyrimidones as orally efficacious mGluR1 antagonists for neuropathic pain.
Sasikumar TK; Qiang L; Burnett DA; Greenlee WJ; Li C; Heimark L; Pramanik B; Grilli M; Bertorelli R; Lozza G; Reggiani A
Bioorg Med Chem Lett; 2009 Jun; 19(12):3199-203. PubMed ID: 19433355
[TBL] [Abstract][Full Text] [Related]
37. Synthesis and biological evaluation of aryl isoxazole derivatives as metabotropic glutamate receptor 1 antagonists: a potential treatment for neuropathic pain.
Cho GH; Kim T; Son WS; Seo SH; Min SJ; Cho YS; Keum G; Jeong KS; Koh HY; Lee J; Pae AN
Bioorg Med Chem Lett; 2015 Mar; 25(6):1324-8. PubMed ID: 25677662
[TBL] [Abstract][Full Text] [Related]
38. Preclinical predictors that the orthosteric mGlu2/3 receptor antagonist LY3020371 will not engender ketamine-associated neurotoxic, motor, cognitive, subjective, or abuse-liability-related effects.
Witkin JM; Monn JA; Li J; Johnson B; McKinzie DL; Wang XS; Heinz BA; Li R; Ornstein PL; Smith SC; Mitch CH; Calligaro DO; Swanson S; Allen D; Phillips K; Gilmour G
Pharmacol Biochem Behav; 2017 Apr; 155():43-55. PubMed ID: 28285123
[TBL] [Abstract][Full Text] [Related]
39. Identification of Nitazoxanide as a Group I Metabotropic Glutamate Receptor Negative Modulator for the Treatment of Neuropathic Pain: An In Silico Drug Repositioning Study.
Ai N; Wood RD; Welsh WJ
Pharm Res; 2015 Aug; 32(8):2798-807. PubMed ID: 25762088
[TBL] [Abstract][Full Text] [Related]
40. Broad spectrum efficacy with LY2969822, an oral prodrug of metabotropic glutamate 2/3 receptor agonist LY2934747, in rodent pain models.
Johnson MP; Muhlhauser MA; Nisenbaum ES; Simmons RM; Forster BM; Knopp KL; Yang L; Morrow D; Li DL; Kennedy JD; Swanson S; Monn JA
Br J Pharmacol; 2017 May; 174(9):822-835. PubMed ID: 28177520
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
